Výsledky vyhledávání

Does exercise-induced ST-segment depression predict benefit of medical intervention in patients recovering from acute myocardial infarction?

Autor: L. Hagerup, N. C. Linde, C. M. Jespersen, N. Holländer, J. Nielsen, J. Launbjerg, E. Steinmetz, P. E. Hven

Publikováno v: Journal of Internal Medicine. 233:33-37

The present study tested the hypothesis that the increased risk in patients with exercise-provoked ST-segment depression recovering from acute myocardial infarction could by abolished by anti-ischaemic medical intervention. Prior to discharge a sympt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7553bc90a55a47691874d90581fcc7d4
https://doi.org/10.1111/j.1365-2796.1993.tb00644.x

Zobrazit plný text záznamu

[Prognosis after primary acute myocardial infarction]

Autor: A L, Gaster, E, Jylling, L, Hagerup, E C, Sahlholdt

Publikováno v: Ugeskrift for laeger. 162(3)

Results from many clinical trials have changed treatment strategies, but due to considerable selection caused by extensive inclusion- and exclusion criteria the results are only valid for smaller groups, while the majority of the patients still suffe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fe32e22262eea4b352bd3a3ee7845ab0
https://pubmed.ncbi.nlm.nih.gov/10850203

Zobrazit plný text záznamu

Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction

Autor: M, Vaage-Nilsen, V, Rasmussen, J F, Hansen, L, Hagerup, M B, Sørensen, O, Pedersen-Bjergaard, K, Mellemgaard, N H, Holländer, I, Nielsen, B M, Sigurd

Publikováno v: Clinical cardiology. 21(12)

Background: Ventricular ectopy early after an acute myocardial infarction (AMI) has previously been demonstrated to predict mortality. Less information is available about the prognostic implications of ventricular ectopy occurring late after an AMI,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e48d84644370c6c7667b31a38cf72406
https://pubmed.ncbi.nlm.nih.gov/9853183

Zobrazit plný text záznamu

[Physical fitness of Danish men and women aged 50 to 80 years]

Autor: P, Era, M, Schroll, L, Hagerup, K S, Jürgensen

Publikováno v: Ugeskrift for laeger. 159(43)

Maximal power in sustained work in originally randomly selected men and women, born in 1914, was studied five times between the ages of 50 and 80 years in a longitudinal design. Of the originally 514 men and 461 women in 1964 living in the Western su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0f4b71791f58ab1f40329592949bd3a0
https://pubmed.ncbi.nlm.nih.gov/9411960

Zobrazit plný text záznamu

Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial

Autor: J F, Hansen, L, Hagerup, B, Sigurd, F, Pedersen, K, Mellemgaard, O P, Bjergaard

Publikováno v: American heart journal. 134(2 Pt 2)

In a double-blind, randomized trial in a consecutive group of postinfarct patients in treatment with diuretic agents for congestive heart failure, the 3 month rate of cardiac events (i.e., death, repeat infarction, unstable angina pectoris, or repeat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a71f77c7f32aafc827436ed2601ea835
https://pubmed.ncbi.nlm.nih.gov/9313623

Zobrazit plný text záznamu

Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group

Autor: J F, Hansen, L, Hagerup, B, Sigurd, F, Pedersen, K, Mellemgaard, O, Pedersen-Bjergaard, L S, Mortensen

Publikováno v: The American journal of cardiology. 79(6)

Angiotensin-converting enzyme (ACE) inhibitors improve survival in patients with congestive heart failure (CHF) after an acute myocardial infarction (AMI), but mortality may be as high as 10% to 15% after 1 year. Verapamil prevents cardiac events aft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::92d31aed45a7de647c19c0710f9daf39
https://pubmed.ncbi.nlm.nih.gov/9070561

Zobrazit plný text záznamu

Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group)

Autor: J F, Hansen, L, Hagerup, B, Sigurd, F, Pedersen, K, Mellemgaard, O, Pedersen-Bjergaard

Publikováno v: Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 15(2)

EFFECTS OF VERAPAMIL AND TRANDOLAPRIL: Progression of heart failure, sudden death and death from re-infarction are the major cause of the increased mortality in postinfarct patients with congestive heart failure. Angiotensin converting enzyme (ACE) i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::617500f792a081a269417e374ceb6028
https://pubmed.ncbi.nlm.nih.gov/9218208

Zobrazit plný text záznamu

Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II)

Autor: M, Vaage-Nilsen, J F, Hansen, K, Mellemgaard, L, Hagerup, B, Sigurd, E, Steinmetz

Publikováno v: International journal of cardiology. 48(3)

The Danish Verapamil Infarction Trial II (DAVIT II) demonstrated from the second postinfarction week, that long term treatment with verapamil significantly improved reinfarction free survival after an acute myocardial infarction (AMI). The present po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b86fd2448451cfc1cbb6622b1c8e77ee
https://pubmed.ncbi.nlm.nih.gov/7782140

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání